Literature DB >> 30793250

Creeping towards broader clinical application of PET myocardial blood flow quantification.

Paul C Cremer1, Frank P DiFilippo2, Manuel D Cerqueira3,2.   

Abstract

Mesh:

Substances:

Year:  2019        PMID: 30793250     DOI: 10.1007/s12350-019-01651-w

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN: 1071-3581            Impact factor:   5.952


× No keyword cloud information.
  14 in total

1.  Improved cardiac risk assessment with noninvasive measures of coronary flow reserve.

Authors:  Venkatesh L Murthy; Masanao Naya; Courtney R Foster; Jon Hainer; Mariya Gaber; Gilda Di Carli; Ron Blankstein; Sharmila Dorbala; Arkadiusz Sitek; Michael J Pencina; Marcelo F Di Carli
Journal:  Circulation       Date:  2011-10-17       Impact factor: 29.690

Review 2.  Anatomic versus physiologic assessment of coronary artery disease. Role of coronary flow reserve, fractional flow reserve, and positron emission tomography imaging in revascularization decision-making.

Authors:  K Lance Gould; Nils P Johnson; Timothy M Bateman; Rob S Beanlands; Frank M Bengel; Robert Bober; Paolo G Camici; Manuel D Cerqueira; Benjamin J W Chow; Marcelo F Di Carli; Sharmila Dorbala; Henry Gewirtz; Robert J Gropler; Philipp A Kaufmann; Paul Knaapen; Juhani Knuuti; Michael E Merhige; K Peter Rentrop; Terrence D Ruddy; Heinrich R Schelbert; Thomas H Schindler; Markus Schwaiger; Stefano Sdringola; John Vitarello; Kim A Williams; Donald Gordon; Vasken Dilsizian; Jagat Narula
Journal:  J Am Coll Cardiol       Date:  2013-08-28       Impact factor: 24.094

3.  Impaired myocardial flow reserve on rubidium-82 positron emission tomography imaging predicts adverse outcomes in patients assessed for myocardial ischemia.

Authors:  Maria C Ziadi; Robert A Dekemp; Kathryn A Williams; Ann Guo; Benjamin J W Chow; Jennifer M Renaud; Terrence D Ruddy; Niroshi Sarveswaran; Rebecca E Tee; Rob S B Beanlands
Journal:  J Am Coll Cardiol       Date:  2011-08-09       Impact factor: 24.094

4.  Preserved coronary flow reserve effectively excludes high-risk coronary artery disease on angiography.

Authors:  Masanao Naya; Venkatesh L Murthy; Viviany R Taqueti; Courtney R Foster; Josh Klein; Mariya Garber; Sharmila Dorbala; Jon Hainer; Ron Blankstein; Frederick Resnic; Marcelo F Di Carli
Journal:  J Nucl Med       Date:  2014-01-09       Impact factor: 10.057

5.  Global coronary flow reserve is associated with adverse cardiovascular events independently of luminal angiographic severity and modifies the effect of early revascularization.

Authors:  Viviany R Taqueti; Rory Hachamovitch; Venkatesh L Murthy; Masanao Naya; Courtney R Foster; Jon Hainer; Sharmila Dorbala; Ron Blankstein; Marcelo F Di Carli
Journal:  Circulation       Date:  2014-11-16       Impact factor: 29.690

6.  Coronary microvascular dysfunction and future risk of heart failure with preserved ejection fraction.

Authors:  Viviany R Taqueti; Scott D Solomon; Amil M Shah; Akshay S Desai; John D Groarke; Michael T Osborne; Jon Hainer; Courtney F Bibbo; Sharmila Dorbala; Ron Blankstein; Marcelo F Di Carli
Journal:  Eur Heart J       Date:  2018-03-07       Impact factor: 29.983

7.  Routine Clinical Quantitative Rest Stress Myocardial Perfusion for Managing Coronary Artery Disease: Clinical Relevance of Test-Retest Variability.

Authors:  Danai Kitkungvan; Nils P Johnson; Amanda E Roby; Monika B Patel; Richard Kirkeeide; K Lance Gould
Journal:  JACC Cardiovasc Imaging       Date:  2016-12-21

8.  Regadenoson versus dipyridamole hyperemia for cardiac PET imaging.

Authors:  Nils P Johnson; K Lance Gould
Journal:  JACC Cardiovasc Imaging       Date:  2015-03-18

9.  Impact of pharmacological stress agent on patient motion during rubidium-82 myocardial perfusion PET/CT.

Authors:  Matthew J Memmott; Christine M Tonge; Kimberley J Saint; Parthiban Arumugam
Journal:  J Nucl Cardiol       Date:  2017-01-04       Impact factor: 5.952

10.  Impact of regadenoson-induced myocardial creep on dynamic Rubidium-82 PET myocardial blood flow quantification.

Authors:  S S Koenders; J D van Dijk; P L Jager; J P Ottervanger; C H Slump; J A van Dalen
Journal:  J Nucl Cardiol       Date:  2019-02-20       Impact factor: 5.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.